Literature DB >> 27130834

Safe reading of chemical pathology reports: the RCPAQAP Report Assessment Survey.

Sabrina Koetsier1, Graham Ross Dallas Jones2, Tony Badrick3.   

Abstract

Pathology reports are a vital component of the request-test-report cycle communicating pathology results to doctors to support clinical decision making. This should be done in a comprehensive, safe and time-efficient manner. As doctors may receive reports from different laboratories these goals can be achieved more readily if reports are formatted in the same way. This study evaluates the formatting of paper reports produced by Australian laboratories for numerical biochemistry results. As part of the RCPAQAP Liquid Serum Chemistry program in 2015, laboratories were invited to supply a routine paper report displaying the results. A total of 37 reports were received for analysis. These reports were assessed for variation in a range of components and, where possible, against relevant Australian standards and guidelines. In summary, there was a wide variation in most of the report components assessed including test names, result alignment, result flagging, sequence of data elements on the page, date formatting and patient name formatting. In most components there was also variation from the Standards. In order to ensure safe result transmission by printed reports there is a need to promote the adoption of current reporting standards and monitor compliance with similar external quality assurance programs. Crown
Copyright © 2016. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  APUTS; Australian standards and guidelines; Pathology report; quality assurance; report rendering.; standardisation

Mesh:

Year:  2016        PMID: 27130834     DOI: 10.1016/j.pathol.2016.02.018

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  1 in total

Review 1.  The role of EQA in harmonization in laboratory medicine - a global effort.

Authors:  Graham R D Jones
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.